NM_000162.5:c.775G>T
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PP2PP3PP4PM5_Strong
This summary comes from the ClinGen Evidence Repository: The c.775G>T variant in the glucokinase gene, GCK, causes an amino acid change of alanine to serine at codon 259 (p.(Ala259Ser)) of NM_000162.5. This variant is predicted to be deleterious by computational evidence, with a REVEL score of 0.744, which is greater than the MDEP VCEP threshold of 0.70 (PP3). GCK is defined by the ClinGen MDEP as a gene that has a low rate of benign missense variation and has pathogenic missense variants as a common mechanism of disease (PP2). Two other missense variants, c.776C>T p.Ala259Val and c.775G>A p.Ala259Thr, have been interpreted as pathogenic by the ClinGen MDEP, and p.Ala259Ser has a greater Grantham distance than p.Ala259Val and p.Ala259Thr (PM5_Strong). This variant was identified in an individual with a clinical history highly specific for GCK-hyperglycemia (FBG 5.5-8 mmol/L and HbA1c 5.6 - 7.6%) (PP4; PMID:30245511). This variant segregated with hyperglycemia/diabetes with one informative meiosis in a single family; however, this does not meet the thresholds for PP1 set by the ClinGen MDEP (PMIDs: 27236918, 30245511). In summary, c.775G>T meets the criteria to be classified as likely pathogenic for monogenic diabetes. ACMG/AMP criteria applied, as specified by the ClinGen MDEP (specification version 1.3.0, approved 8/11/2023): PP3, PP2, PM5_Strong, PP4. LINK:https://erepo.genome.network/evrepo/ui/classification/CA367400582/MONDO:0015967/086
Frequency
Consequence
NM_000162.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Monogenic diabetes Pathogenic:1
The c.775G>T variant in the glucokinase gene, GCK, causes an amino acid change of alanine to serine at codon 259 (p.(Ala259Ser)) of NM_000162.5. This variant is predicted to be deleterious by computational evidence, with a REVEL score of 0.744, which is greater than the MDEP VCEP threshold of 0.70 (PP3). GCK is defined by the ClinGen MDEP as a gene that has a low rate of benign missense variation and has pathogenic missense variants as a common mechanism of disease (PP2). Two other missense variants, c.776C>T p.Ala259Val and c.775G>A p.Ala259Thr, have been interpreted as pathogenic by the ClinGen MDEP, and p.Ala259Ser has a greater Grantham distance than p.Ala259Val and p.Ala259Thr (PM5_Strong). This variant was identified in an individual with a clinical history highly specific for GCK-hyperglycemia (FBG 5.5-8 mmol/L and HbA1c 5.6 - 7.6%) (PP4; PMID: 30245511). This variant segregated with hyperglycemia/diabetes with one informative meiosis in a single family; however, this does not meet the thresholds for PP1 set by the ClinGen MDEP (PMIDs: 27236918, 30245511). In summary, c.775G>T meets the criteria to be classified as likely pathogenic for monogenic diabetes. ACMG/AMP criteria applied, as specified by the ClinGen MDEP (specification version 1.3.0, approved 8/11/2023): PP3, PP2, PM5_Strong, PP4. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.